Heller DA

ORCID: 0000-0002-6866-0000 · 2 papers in corpus
diagnostic-accuracy 2022
Nature biomedical engineering ·doi:10.1038/s41551-022-00860-y

Serum biomarkers are often insufficiently sensitive or specific to facilitate cancer screening or diagnostic testing. In ovarian cancer, the few established serum biomarkers are highly specific, yet insufficiently sensitive to detect early-…

lab-animal 2018
Science advances ·doi:10.1126/sciadv.aaq1090

Patients with high-grade serous ovarian carcinoma (HGSC) exhibit poor 5-year survival rates, which may be significantly improved by early-stage detection. The U.S. Food and Drug Administration-approved biomarkers for HGSC-CA-125 (cancer ant…